RDNT vs. LLY

Last updated Jun 3, 2026

RDNT (RadNet, Inc.) and LLY (Eli Lilly and Company) are both stocks. Both are in the Healthcare sector — RDNT in Diagnostics & Research, LLY in Drug Manufacturers - General. Over the past 10 years, RDNT returned 26.30%/yr vs 32.48%/yr for LLY. At a 0.12 correlation, their price movements are largely independent.

Performance

RDNT vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RadNet, Inc. (RDNT) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RDNT achieves a -23.88% return, which is significantly lower than LLY's -0.64% return. Over the past 10 years, RDNT has underperformed LLY with an annualized return of 26.30%, while LLY has yielded a comparatively higher 32.48% annualized return.

RDNT

• 1D: 2.68%
• 1M: -4.47%
• YTD: -23.88%
• 6M: -31.08%
• 1Y: -6.78%
• 3Y*: 21.37%
• 5Y*: 15.65%
• 10Y*: 26.30%

LLY

• 1D: -1.67%
• 1M: 10.66%
• YTD: -0.64%
• 6M: 2.07%
• 1Y: 43.44%
• 3Y*: 34.95%
• 5Y*: 40.65%
• 10Y*: 32.48%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RDNT vs. LLY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RDNT RadNet, Inc.	-23.88%	2.16%	100.86%	84.65%	-37.46%	53.86%	-3.60%	99.61%	0.69%	56.59%
LLY Eli Lilly and Company	-0.64%	40.25%	33.30%	60.91%	34.26%	66.08%	31.04%	16.14%	40.45%	17.83%

Correlation

The correlation between RDNT and LLY is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.21
Correlation (5Y) Calculated over the trailing 5-year period	0.21
Correlation (10Y) Calculated over the trailing 10-year period	0.17
Correlation (All Time) Calculated using the full available price history since Jan 6, 1997	0.12

Fundamentals

Market Cap RDNT : $4.19B LLY : $953.37B
EPS RDNT : -$0.19 LLY : $28.14
PS Ratio RDNT : 1.91 LLY : 13.23
PB Ratio RDNT : 3.87 LLY : 30.56
Total Revenue (TTM) RDNT : $2.14B LLY : $72.25B
Gross Profit (TTM) RDNT : $197.72M LLY : $59.75B
EBITDA (TTM) RDNT : $319.35M LLY : $32.97B

Return for Risk

RDNT vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RDNT

RDNT Risk / Return Rank: 33
RDNT Sharpe Ratio Rank: 34
RDNT Sortino Ratio Rank: 31
RDNT Omega Ratio Rank: 31
RDNT Calmar Ratio Rank: 35
RDNT Martin Ratio Rank: 34

LLY

LLY Risk / Return Rank: 72
LLY Sharpe Ratio Rank: 75
LLY Sortino Ratio Rank: 69
LLY Omega Ratio Rank: 70
LLY Calmar Ratio Rank: 73
LLY Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RDNT vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for RadNet, Inc. (RDNT) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RDNT	LLY	Difference
Sharpe ratio Return per unit of total volatility	-0.16	1.15	-1.31
Sortino ratio Return per unit of downside risk	0.07	1.71	-1.65
Omega ratio Gain probability vs. loss probability	1.01	1.23	-0.22
Calmar ratio Return relative to maximum drawdown	-0.15	1.92	-2.06
Martin ratio Return relative to average drawdown	-0.31	4.78	-5.09
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RDNT vs. LLY - Sharpe Ratio Comparison

The current RDNT Sharpe Ratio is -0.16, which is lower than the LLY Sharpe Ratio of 1.15. The chart below compares the historical Sharpe Ratios of RDNT and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RDNT	LLY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.16	1.15	-1.31
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.35	1.25	-0.90
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.55	1.08	-0.53
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	0.57	-0.39

Drawdowns

RDNT vs. LLY - Drawdown Comparison

The maximum RDNT drawdown since its inception was -92.15%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for RDNT and LLY.

Drawdown Indicators

	RDNT	LLY	Difference
Max Drawdown Largest peak-to-trough decline	-92.15%	-68.24%	-23.91%
Max Drawdown (1Y) Largest decline over 1 year	-37.99%	-23.64%	-14.35%
Max Drawdown (3Y) Largest decline over 3 years	-46.84%	-34.48%	-12.36%
Max Drawdown (5Y) Largest decline over 5 years	-60.24%	-34.48%	-25.76%
Max Drawdown (10Y) Largest decline over 10 years	-73.43%	-34.48%	-38.95%
Current Drawdown Current decline from peak	-37.13%	-5.56%	-31.57%
Average Drawdown Average peak-to-trough decline	-44.08%	-19.22%	-24.86%
Ulcer Index Depth and duration of drawdowns from previous peaks	17.79%	9.48%	+8.31%

Volatility

RDNT vs. LLY - Volatility Comparison

RadNet, Inc. (RDNT) has a higher volatility of 11.17% compared to Eli Lilly and Company (LLY) at 9.11%. This indicates that RDNT's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RDNT	LLY	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.17%	9.11%	+2.06%
Volatility (6M) Calculated over the trailing 6-month period	30.83%	26.83%	+4.00%
Volatility (1Y) Calculated over the trailing 1-year period	42.55%	37.88%	+4.67%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.84%	32.79%	+12.05%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	48.13%	30.15%	+17.98%

Dividends

RDNT vs. LLY - Dividend Comparison

RDNT has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.61%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
LLY Eli Lilly and Company	0.61%	0.56%	0.67%	0.78%	1.07%	1.23%	1.75%	1.96%	1.94%	2.46%	2.77%	2.37%
RDNT RadNet, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

RDNT vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between RadNet, Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

RDNT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, RadNet, Inc. reported a gross profit of -19.85M and revenue of 575.63M. Therefore, the gross margin over that period was -3.5%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

RDNT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, RadNet, Inc. reported an operating income of -19.85M and revenue of 575.63M, resulting in an operating margin of -3.5%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

RDNT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, RadNet, Inc. reported a net income of -33.47M and revenue of 575.63M, resulting in a net margin of -5.8%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.

Frequently Asked Questions

Can I hold both RDNT and LLY in my portfolio?

RDNT and LLY have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RDNT or LLY?

RDNT has higher volatility (11.17%) compared to LLY (9.11%). In terms of maximum drawdown, RDNT dropped -92.15% vs LLY's -68.24%.

Which has better risk-adjusted returns?

LLY currently has the higher Sharpe Ratio (1.15 vs -0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.